Home - Products - Apoptosis - PKA - Fasudil (HA-1077) hydrochloride

Fasudil (HA-1077) hydrochloride

CAS No. 105628-07-7

Fasudil (HA-1077) hydrochloride( HA-1077 | AT-877 )

Catalog No. M10257 CAS No. 105628-07-7

Fasudil hydrochloride(HA-1077; AT-877) is a potent inhibitor of ROCK-II, PKA, PKG, PKC, and MLCK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 32 In Stock
100MG 41 In Stock
200MG 61 In Stock
500MG 87 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fasudil (HA-1077) hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Fasudil hydrochloride(HA-1077; AT-877) is a potent inhibitor of ROCK-II, PKA, PKG, PKC, and MLCK.
  • Description
    Fasudil hydrochloride(HA-1077; AT-877) is a potent inhibitor of ROCK-II, PKA, PKG, PKC, and MLCK with Ki of 0.33 μM, 1.6 μM, 1.6 μM, 3.3 μM and 36 μM, respectively.(In Vitro):Fasudil Hydrochloride (100 μM) inhibits cell spreading, the formation of stress fibers, and expression of α-SMA with concomitant suppression of cell growth in rat HSCs (hepatic stellate cells) and human HSC-derived TWNT-4 cells.Fasudil Hydrochloride (50-100 μM; 24 hours) inhibits the LPA (lysophoaphatidic acid)-induced phosphorylation of ERK1/2, JNK, and p38 detected by western blotting in rat HSCs and human HSC-derived TWNT-4 cells.Fasudil Hydrochloride (25-100 μM; 24 hours) suppresses transcription of collagen and TIMP, stimulates transcription of MMP-1 in human HSC-derived TWNT-4 cells. (In Vivo):Fasudil Hydrochloride (10 mg/kg; i.v.; 1 h before operation) exhibits protectable effects on cardiovascular disease and reduces the activation of JNK and attenuates mitochondrial-nuclear translocation of AIF under ischemic injury.Fasudil Hydrochloride (50 mg/kg/d; i.p.) inhibits acute and relapsing EAE (experimental autoimmune encephalomyelitis) induced by proteolipid protein PLP p139-151, reduces lymphocytes proliferation, results downregulation of interleukin (IL)-17 and a marked decrease of the IFN-γ/IL-4 ratio.Fasudil Hydrochloride (100 mg/kg/d; p.o.) significantly reduces incidence and pathological examination score of EAE (experimental autoimmune encephalomyelitis) in SJL/J mice, decreases inflammation, demyelination, axonal loss and APP positivein spinal cord in mice.
  • In Vitro
    Fasudil Hydrochloride (100 μM) inhibits cell spreading, the formation of stress fibers, and expression of α-SMA with concomitant suppression of cell growth in rat HSCs (hepatic stellate cells) and human HSC-derived TWNT-4 cells.Fasudil Hydrochloride (50-100 μM; 24 hours) inhibits the LPA (lysophoaphatidic acid)-induced phosphorylation of ERK1/2, JNK, and p38 detected by western blotting in rat HSCs and human HSC-derived TWNT-4 cells.Fasudil Hydrochloride (25-100 μM; 24 hours) suppresses transcription of collagen and TIMP, stimulates transcription of MMP-1 in human HSC-derived TWNT-4 cells. Western Blot Analysis Cell Line:Rat HSCs and human HSC-derived TWNT-4 cells Concentration:50 μM; 100 μM Incubation Time:24 hours Result:Suppressed the LPA-induced phosphorylation of ERK1/2, JNK and p38 MAPK by 60%, 70%,and 90%, respectively.RT-PCR Cell Line:Rat HSCs and human HSC-derived TWNT-4 cells Concentration:25 μM; 50 μM; 100 μM 24 hours Incubation Time:24 hours Result:Reduced the expression of type I collagen, a-SMA, and TIMP-1.
  • In Vivo
    Fasudil Hydrochloride (10 mg/kg; i.v.; 1 h before operation) exhibits protectable effects on cardiovascular disease and reduces the activation of JNK and attenuates mitochondrial-nuclear translocation of AIF under ischemic injury.?Fasudil Hydrochloride (50 mg/kg/d; i.p.) inhibits acute and relapsing EAE (experimental autoimmune encephalomyelitis) induced by proteolipid protein PLP p139-151, reduces lymphocytes proliferation, results downregulation of interleukin (IL)-17 and a marked decrease of the IFN-γ/IL-4 ratio.Fasudil Hydrochloride (100 mg/kg/d; p.o.) significantly reduces incidence and pathological examination score of EAE (experimental autoimmune encephalomyelitis) in SJL/J mice, decreases inflammation, demyelination, axonal loss and APP positivein spinal cord in mice. Animal Model:Myocardial ischemia and reperfusion in rat (250-300 g)Dosage:10 mg/kg Administration:Intravenous injection; 1 h before operation Result:Activated the Rho-kinase, JNK, and resulted AIF translocated to the nucleus.Inhibited Rho-kinase activity, and reduced myocardial infarct size and heart cell apoptosis.
  • Synonyms
    HA-1077 | AT-877
  • Pathway
    Apoptosis
  • Target
    PKA
  • Recptor
    PKA| PKG| PKC| ROCK2| MLCK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    105628-07-7
  • Formula Weight
    327.83
  • Molecular Formula
    C14H18ClN3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 65 mg/mL (198.27 mM); DMSO: 5 mg/mL (15.25 mM)
  • SMILES
    Cl.Cl.O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ono-Saito N, et al. Pharmacol Ther, 1999, 82(2-3), 123-13
molnova catalog
related products
  • GUANOSINE 3':5'-CYCL...

    GUANOSINE 3':5'-CYCLIC MONOPHOSPHATE also known as cGMP is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones including acetylcholine insulin and oxytocin.

  • H-89

    H-89 is a selective and potent protein kinase A inhibitor (IC50: 48 nM), a candidate cardioprotectant, induces spatial learning impairment in rats, and can be used to study myocardial infarction.

  • AP-C2

    AP-C2 is a potent small molecule guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) inhibitor with a pIC50 of 5.2 for cGKII.